Vascular dementia is a decline in memory, thinking skills, and self-care that occurs due to strokes in the areas of the brain ...

Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus wasn’t better than a placebo at delaying the progression of Alzheimer’s disease. It shared few details beyond saying the ...

Alzheimer's disease is a type of dementia, but not all dementia is Alzheimer's. Dementia symptoms include memory loss, problem-solving trouble, and trouble completing tasks. Seeking early diagnosis ...

Most types of dementia involve memory loss, impaired thinking skills, and loss of independence. Alzheimer's disease is the most common type of dementia, and some new diagnostic tests can help ...

Data from the Evoke trials suggests that GLP-1 drugs that treat type 2 diabetes do not have a significant effect on Alzheimer ...

Mixed dementia, also known as multifactorial dementia, is when you have brain changes from two or more types of dementia at the same time. In mild cognitive decline, you may have trouble remembering ...

"While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer's disease, the extensive body of ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

Type 1 diabetes was linked to increased risk for dementia, especially vascular dementia, non-Alzheimer-nonvascular dementia, and Alzheimer disease.

‘Mixed dementia’ is a condition in which a person has more than one type of dementia. This affects at least 1 in 10 people who are diagnosed with dementia. A lot of people have more than one type of ...